Effects of promoters on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in the rat.
It has been shown that the occurrence of the preneoplastic lesion, papillary or nodular hyperplasia (PN hyperplasia) in rat urinary bladder induced by carcinogens is correlated with that of cancer. Therefore, the promoting effects of chemicals in two-stage bladder carcinogenesis were judged by measuring their ability to induce PN hyperplasia in rats. Male rats were given N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) for 4 weeks and then one of 16 test chemicals for 32 to 34 weeks. Saccharin, ascorbate, DL-tryptophan, allopurinol, and diphenyl promoted development of PN hyperplasia. The dose-response of the promoters were examined in both sexes of rats by administration of saccharin at doses of 0.04, 0.2, 1.0 and 5.0% for 32 weeks after BBN treatment. The occurrence of PN hyperplasia was significantly increased in the group given 5% saccharin. Dose-response curves showed enhanced hyperplastic responses in both sexes given 0.2 to 5% saccharin. The organ specificities of promoters were studied in rats initiated with BBN or 2-acetylamino-fluorene (2-AAF) followed by phenobarbital or saccharin for 32 weeks. Phenobarbital greatly enhanced hepatocarcinogenesis. Saccharin significantly enhanced the occurrence of both BBN-induced and 2-AAF-induced PN hyperplasia. However, there was no effect of phenobarbital on the urinary bladder or of saccharin on the liver. The rats showed a strain difference in susceptibility of the urinary bladder to saccharin; ACI rats were most susceptible and Sprague Dawley rats were most resistant to saccharin. The membrane potential of superficial epithelial cells in the urinary bladder of rats treated with saccharin was measured with an intracellular microelectrode and found to be higher than that of controls.
D015073:2-Acetylaminofluorene; D000818:Animals; D002085:Butylhydroxybutylnitrosamine; D002273:Carcinogens; D004305:Dose-Response Relationship, Drug; D008113:Liver Neoplasms / Q000139:chemically induced; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000503:physiopathology; D009602:Nitrosamines; D010634:Phenobarbital; D011230:Precancerous Conditions / Q000473:pathology; D051381:Rats; D012439:Saccharin / Q000494:pharmacology; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology
D002273:Carcinogens; D009602:Nitrosamines; D002085:Butylhydroxybutylnitrosamine; D015073:2-Acetylaminofluorene; D012439:Saccharin; D010634:Phenobarbital